LBA10Primary results of ALESIA: A randomised, phase III,...

Annals of Oncology 2018 / 10 Vol. 29; Iss. suppl_8

LBA10Primary results of ALESIA: A randomised, phase III, open-label study of alectinib vs crizotinib in Asian patients with treatment-naïve ALK+ advanced NSCLC

Zhou, C, Lu, Y, Kim, S-W, Reungwetwattana, T, Zhou, J, Zhang, Y, He, J, Yang, J-J, Cheng, Y, Lee, S H, Bu, L, Xu, T, Yang, L, Wang, C, Morcos, P N, Mitry, E, Liu, T, Zhang, L
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
29
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdy424.062
Date:
October, 2018
File:
PDF, 100 KB
english, 2018
Conversion to is in progress
Conversion to is failed